ABEO Abeona Therapeutics Inc.

NASDAQ
$5.99

Abeona Therapeutics Inc. (ABEO) is expected to report earnings on November 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.7% since its last earnings release on August 13, 2026.

Abeona Therapeutics Missed Consensus Estimates
Thursday, August 13, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 7:30 AM ET
Earnings Whisper
-
vs ($0.14)
Rev est $21.23M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.16

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases.

Sector

Healthcare

Industry

Biotechnology